Biodesix, Inc. (BDSX)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$29.12
+3.45%
Mkt Cap $154.34M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$31.00
Range $26.00 – $35.00
Implied Upside
+6.5%
Consensus $31.00 vs current $29.12